Back to Search
ROBERT KRATZKE, MD
MD
Medical Oncology Physician
NPI: 1497845861IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
40486(MN)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
PMID 18379362·J Thorac Oncol·2008
8-other
Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas.
PMID 19660401·J Thorac Cardiovasc Surg·2010
8-other
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II.
PMID 19132295·Invest New Drugs·2010
8-other
Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor.
PMID 19401697·Br J Cancer·2009
3-trial
Cap-dependent translation blockade and fixed dose-rate gemcitabine: interaction in an in vitro bioreactor system.
PMID 19442436·Cancer Lett·2009
8-other
Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma.
PMID 19603014·Br J Cancer·2009
7-preclinical
Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer.
PMID 19633472·J Thorac Oncol·2009
3-trial
Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
PMID 19021967·Ann Thorac Surg·2008
4-observational
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
PMID 18281656·J Clin Oncol·2008
3-trial
Gene silencing for epidermal growth factor receptor variant III induces cell-specific cytotoxicity.
PMID 19001441·Mol Cancer Ther·2008
7-preclinical
Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system.
PMID 17429628·Cancer Chemother Pharmacol·2008
8-other
Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer.
PMID 17532379·Ann Thorac Surg·2007
4-observational
Short versus continuous gemcitabine treatment of non-small cell lung cancer in an in vitro cell culture bioreactor system.
PMID 17651859·Lung Cancer·2007
4-observational
Central intranodal blood vessel: a new EUS sign described in mediastinal lymph nodes.
PMID 17383457·Gastrointest Endosc·2007
8-other
Endoscopic ultrasound and positron emission tomography for lung cancer staging.
PMID 16682256·Clin Gastroenterol Hepatol·2006
3-trial
EUS-guided FNA for the diagnosis of advanced lung cancer.
PMID 16733110·Gastrointest Endosc·2006
8-other
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award.
PMID 16928523·Ann Thorac Surg·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 424 HARVARD ST SE
MINNEAPOLIS, MN 55455 - Phone
- (612) 625-5411
Quick Facts
- NPI
- 1497845861
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile